Hexonic derivatives as human GABA-AT inhibitors: A molecular docking approach

  • Dharmaraj Senthilkumar School of Bio Sciences and Technology, VIT University, Vellore, Tamilnadu
  • Krishnan Anbarasu School of Bio Sciences and Technology, VIT University, Vellore, Tamilnadu
  • Sivaraman Jayanthi School of Bio Sciences and Technology, VIT University, Vellore, Tamilnadu
Keywords: ?-Aminobutyric acid aminotransferase, Epilepsy, Molecular docking


Human ?-aminobutyric acid aminotransferase (GABA-AT), a pyridoxal phosphate dependent enzyme is responsible for the degradation of the inhibitory neurotransmitter GABA. Currently, GABA-AT is a potential drug target for epilepsy due to the selective inhibition in brain. In this computational study, we mainly focus on screening of novel lead candidates against GABA-AT using hexonic derivatives. Structure based virtual screening is performed in Vina that screened top hits based on least binding affinity. Further re-docking on hits is performed in AutoDock results in identification of leads with favorable binding energy and hydrogen bond interactions confirmed the effective inhibition. In conclusion, leads 3-aminohex-5-enoic acid and AG-E-60842 can acts as specific leads for GABA-AT and assist in discovery of novel anti-epileptic drugs.


Download data is not yet available.
519 Read


Agrawal P, Thakur Z, Kulharia M. Homology modeling and structural validation of tissue factor pathway inhibitor. Bioinformation. 2013; 9: 808-12.

Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990; 215: 403-10.

Bolton E, Wang Y, Thiessen PA, Bryant SH. PubChem: Integrated platform of small molecules and biological activities. In: Annual reports in computational chemistry. Vol 4. 2008.

Cheng T, Li Q, Zhou Z, Wang Y, Bryant SH. Structure-based virtual screening for drug discovery: A problem-centric review. AAPS J. 2012; 14: 13341.

Clift MD, Silverman RB. Synthesis and evaluation of novel aromatic substrates and competitive inhibitors of GABA aminotransferase. Bioorg Med Chem Lett. 2008; 18: 312225.

DeLano WL. Pymol. Portland, OR, Schrodinger LLC, 2009.

Eswar N, Marti-Renom MA, Webb B, Madhusudhan MS, Eramian D, Shen M, Pieper U, Sali A. Comparative protein structure modeling with MODELLER. Curr Protoc Bioinformatics. Chapter 5. Unit 5.6. 2006.

Karlsson A, Fonnum F, Malthe-Sorenssen D, Storm-Mathisen J. Effect of the convulsive agent 3-mercaptopropionic acid on the basal levels of GABA, other amino acids and glutamate decarboxylase in different regions of the rat brain. Biochem. Pharmacol. 1974; 23: 3053-61.

Khan HN, Rashid H, Kulsoom S. Homology modeling of ?-aminobutyrate-aminotransferase, a pyridoxal phosphate-dependent enzyme of Homo sapiens: Molecular modeling approach to rational drug design against epilepsy. Afr J Biotechnol. 2011; 10: 5916-26.

Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: A program to check the stereochemical quality of protein structures. J App Cryst. 1993; 26: 283-91.

Laurie ATR, Jackson RM. Q-SiteFinder: An energy-based method or the prediction of proteinligand binding sites. Bioinformatics. 2005; 21: 1908-16.

Lytton WW. Computer modeling of epilepsy. Nat Rev Neurosci. 2008; 9: 62637.

Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJJ. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem. 1998; 19: 1639-62.

Osolodkin DI, Chupakhin VI, Palyulin VA, Zefirov NS. Mole-cular modeling of ligand-receptor interactions in GABA C receptor. J Mol Graph Model. 2009; 27: 813-21.

Sayle RA, Milner-White EJ. RasMol: Biomolecular graphics for all. Trends Biochem Sci. 1995; 20: 374.

Panigrahi SK, Desiraju GR. Strong and weak hydrogen bonds in the protein-ligand interface. Proteins 2007; 67: 128-41.

Rangaraju A, Rao AV. A review on molecular docking: Novel tool in drug design and analysis. J Harmon Res Pharm. 2013; 2: 215-21.

Rajesh PK, Rohini K, Srikumar PS. Anti-tuberculosis drugs against mycobacterium tuberculosis PKNB and mutants I33D/ D76A: A comparative docking study. Int J Pharm Pharm Sci. 2014; 6: 662-64.

Rohini K, Srikumar PS. Structural insights on mycobacterium tuberculosis thiazole synthase: A molecular dynamics/docking approach. Appl Biochem Biotechnol. 2013; 169: 1790-98.

Silverman RB, Durkee SC, Invergo BJ. 4-Amino-2-(substituted methyl)-2-butenoic acids: Substrates and potent inhibitors of ?-aminobutyric acid aminotransferase. J Med Chem. 1986; 29: 764-70.

Smith AJ, Simpson PB. Methodological approaches for the study of GABAA receptor pharmacology and functional responses. Anal Bioanal Chem. 2003; 377: 84351.

Storici P, De Biase D, Bossa F, Bruno S, Mozzarelli A, Peneff C, Silverman RB, Schirmer T. Structures of gamma-aminobutyric acid (GABA) aminotransferase, a pyridoxal 5'-phosphate, and [2Fe-2S] cluster-containing enzyme, complexed with gamma-ethynyl-GABA and with the antiepilepsy drug vigabatrin. J Biol Chem. 2004; 279: 363-73.

Tetko IV, Gasteiger J, Todeschini R, Mauri A, Livingstone D, Ertl P, Palyulin VA, Radchenko EV, Zefirov NS, Makarenko AS, Tanchuk VY, Prokopenko VV. Virtual computational chemistry laboratory design and description. J Comput Aid Mol Des. 2005; 19: 453-63.

Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010; 31: 45561.

Yadav M, Singh G. Virtual screening of ligand molecules for target protein CYP26A1 by using AutoDock-Vina. Int J Innov Res Sci Eng Technol. 2013; 2: 4915-20.

How to Cite
Senthilkumar, D., K. Anbarasu, and S. Jayanthi. “Hexonic Derivatives As Human GABA-AT Inhibitors: A Molecular Docking Approach”. Bangladesh Journal of Pharmacology, Vol. 10, no. 1, Jan. 2015, pp. 1-6, doi:10.3329/bjp.v10i1.20642.
Research Articles